Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05206422 · ClinicalTrials.gov registry record · NA
DORAYA-HF Early Feasibility Study
A NA study of Acute Decompensated Heart Failure, sponsored by Revamp Medical.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 14
- Study locations
NCT05206422 is a NA study of Acute Decompensated Heart Failure that is active but no longer recruiting, run by Revamp Medical. The registered enrollment target is 30 participants, below the 457-participant average among 12 other Acute Decompensated Heart Failure trials with a reported enrollment target (93% lower). The trial reports 14 study locations across 8 states.
The verdict
NCT05206422, a NA study of Acute Decompensated Heart Failure, is active but no longer recruiting, sponsored by Revamp Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 14
- Study locations
Study Summary
The study objective is to evaluate the feasibility of the Doraya Catheter and measure clinical performance and safety endpoints, in ADHF patients deemed to have insufficient diuretic response.
Conditions Studied
Interventions
- DEVICE Doraya Catheter
Study Locations (14)
California
- Zuckerberg San Francisco General - San Francisco
- San Francisco VA - San Francisco
- UCSF - San Francisco
Ohio
- The Christ Hospital - Cincinnati
- The MetroHealth System - Cleveland
- The Ohio State University - Columbus
Georgia
- Piedmont Hospital - Augusta
- Northeast Georgia Medical Center - Gainesville
Texas
- Baylor University Medical Center - Dallas
- CHI St. Luke's Health-Baylor St. Luke's Medical Center - Houston
Florida
- Cleveland Clinic - Weston
Missouri
- Christian Hospital - St Louis
Oklahoma
- Oklahoma Heart - Oklahoma City
South Carolina
- Prisma Health - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-10-05 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05206422
The ClinicalTrials.gov registry entry for NCT05206422 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 457-participant average among 12 other Acute Decompensated Heart Failure trials with a reported enrollment target (93% lower). The listed sponsor is Revamp Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Decompensated Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Doraya Catheter is the first listed.
NCT05206422 reports 14 study locations spanning 8 distinct geographic areas - top geographies include California, Ohio, Georgia.
Frequently Asked Questions
What is clinical trial NCT05206422 about?
NCT05206422 is a clinical study titled "DORAYA-HF Early Feasibility Study". The study objective is to evaluate the feasibility of the Doraya Catheter and measure clinical performance and safety endpoints, in ADHF patients deemed to have insufficient diuretic response.
What is the current status of trial NCT05206422?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-10-05. Estimated completion is 2026-03-31.
What conditions does trial NCT05206422 study?
This clinical trial studies the following conditions: Acute Decompensated Heart Failure.
What interventions are being tested in trial NCT05206422?
The interventions under investigation include: Doraya Catheter (DEVICE).
Who is sponsoring clinical trial NCT05206422?
This trial is sponsored by Revamp Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05206422 being conducted?
This trial has 14 study locations across California, Florida, Georgia, Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Decompensated Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Low Level Tragus Stimulation in Acute Decompensated Heart Failure
RECRUITING · NA
-
Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study
ACTIVE NOT RECRUITING · NA
-
RAAS Optimization for Acute CHF Patients
COMPLETED · NA
-
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS)
COMPLETED · NA
-
Evaluation of Cardiopulmonary Diseases by Ultrasound
COMPLETED · NA
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.